The latest medical news on Clinical Pharmacology

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about clinical pharmacology gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
Fierce Pharma

AstraZeneca is counting on its newly acquired Soliris to help generate billions toward its ambitious 2023 sales goal, but one prominent cost watchd...

Fierce Pharma

Amgen, with the help of the International Federation of Psoriasis Associations, is calling on patient groups to brainstorm ways to fill longstandin...

Fierce Pharma

Junshi Biosciences has formed a joint venture to develop mRNA drugs and vaccines. Novartis recorded strong growth for its China business in the sec...

Fierce Pharma

Takeda is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines.

Fierce Pharma

Lumen has snagged the lease to a former Seattle bakery that it will soon use to make large volumes of biologics grown in the popular food algae spi...

Pharma Times

New recommendations outlined include advice for managing C. difficile infection in both community and hospital settings

Pharma Times

Real-world data shows jab is effective after one dose against hospitalisation/death caused by Beta and Delta variants

Pharma Times

Microbiome-based therapeutic failed to improve clinical remission rates among mild-to-moderate ulcerative colitis patients

Pharma Times

NHS England has set out new plans to introduce five new waiting time guarantees for mental health services

FDA Daily Update

Advisory Committees FDA Advisory Panel Turns Down FibroGen’s Roxadustat for Anemia San Francisco biotech FibroGen’s investigational drug for anemia...

FDA Daily Update

View the entire issue.

FDA Daily Update

The anti-Aduhelm uproar consuming the Alzheimer’s community is due to a campaign of “extensive misinformation and misunderstanding,” Biogen executi...